[HTML][HTML] Mechanisms underlying potential therapeutic approaches for COVID-19
A Benani, S Ben Mkaddem - Frontiers in Immunology, 2020 - frontiersin.org
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), which is a betacoronavirus, and is associated with cytokine …
coronavirus 2 (SARS-CoV-2), which is a betacoronavirus, and is associated with cytokine …
Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications
Such testing and trying time probably never seen before in the human history. The novel
coronavirus disease abbreviated as COVID-19 is the ongoing health crisis which entered …
coronavirus disease abbreviated as COVID-19 is the ongoing health crisis which entered …
Targeting cytokine storm to manage patients with COVID-19: a mini-review
N Roshanravan, F Seif, A Ostadrahimi… - Archives of medical …, 2020 - Elsevier
Corona Virus Disease 2019 (COVID-19) pandemic is rapidly spreading all over the world.
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …
Excessive immune responses trigger life-threatening cytokine release syndrome (CRS) …
[HTML][HTML] SARS-coV-2 treatment approaches: numerous options, no certainty for a versatile virus
S Iacob, DG Iacob - Frontiers in Pharmacology, 2020 - frontiersin.org
SARS-CoV-2 is the most recent coronavirus which crossed the species barrier in 2019 and
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …
provoked a still ongoing and dangerous pandemic known as coronavirus disease 2019 …
COVID-19 associated complications and potential therapeutic targets
JD Monpara, SJ Sodha, PK Gupta - European Journal of Pharmacology, 2020 - Elsevier
The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged
as severe public health issue crippling world health care systems. Substantial knowledge …
as severe public health issue crippling world health care systems. Substantial knowledge …
[HTML][HTML] Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
C Gotera - International braz j urol, 2020 - SciELO Brasil
ABSTRACT Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health …
syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health …
[HTML][HTML] COVID-19: in the eye of the cytokine storm
R De la Rica, M Borges, M Gonzalez-Freire - Frontiers in immunology, 2020 - frontiersin.org
The dysregulated release of cytokines has been identified as one of the key factors behind
poorer outcomes in COVID-19. This “cytokine storm” produces an excessive inflammatory …
poorer outcomes in COVID-19. This “cytokine storm” produces an excessive inflammatory …
[PDF][PDF] Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2
IF Chukwuma, VO Apeh, OF Chiletugo - Acta Virol, 2021 - researchgate.net
Coronavirus infection is now the leading cause of death globally. Despite the several
bedsides-to-bench investigations carried out by researchers all over the world to identify the …
bedsides-to-bench investigations carried out by researchers all over the world to identify the …
[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature
Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …
[HTML][HTML] Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, previously named 2019-nCov), a novel …